2014
DOI: 10.1002/pbc.24997
|View full text |Cite
|
Sign up to set email alerts
|

Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001–2010

Abstract: Though most of the GCCR-registered patients with rare malignant tumors are treated within GPOH trials, there is a considerable number of patients that have been diagnosed and treated outside the structures of the GPOH. These patients should be reported to the recently founded German Pediatric Rare Tumor Registry (STEP). Active data accrual and the development of appropriate structures will allow for better registration and improvement of medical care in these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
12
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 28 publications
(14 citation statements)
references
References 22 publications
2
12
0
Order By: Relevance
“…This study concerned patients prospectively registered under national cooperative projects dedicated to rare pediatric tumors in Italy (Tumori Rari in Età Pediatrica [TREP]) (n = 43), Poland (Polish Pediatric Rare Tumor Study Group, n = 23), Germany (Seltene Tumorerkrankungen in der Pädiatrie, n = 31), and France (Groupe FRAnCais Des TUmeurs Rares de l'Enfant [FRaCTurE], n = 43). Additional cases were collected from the prospective German Central Malignant Melanoma Registry (CMMR, n = 65) and from a dermatology registry in Israel (n = 14).…”
Section: Methodsmentioning
confidence: 99%
“…This study concerned patients prospectively registered under national cooperative projects dedicated to rare pediatric tumors in Italy (Tumori Rari in Età Pediatrica [TREP]) (n = 43), Poland (Polish Pediatric Rare Tumor Study Group, n = 23), Germany (Seltene Tumorerkrankungen in der Pädiatrie, n = 31), and France (Groupe FRAnCais Des TUmeurs Rares de l'Enfant [FRaCTurE], n = 43). Additional cases were collected from the prospective German Central Malignant Melanoma Registry (CMMR, n = 65) and from a dermatology registry in Israel (n = 14).…”
Section: Methodsmentioning
confidence: 99%
“…In Germany, pediatric melanoma cases have been collected within the German Central Malignant Melanoma Registry and the German Childhood Cancer Registry for more than 30 years [3]. Additional information on incidence, clinical characteristics and outcome of pediatric melanoma and other rare tumors in children and adolescents was assessed within the Rare Pediatric Tumor Registry (STEP, Seltene Tumorerkrankungen in der Paediatrie) of the German Society for Pediatric Oncology and Hematology (GPOH) launched in 2012 [5].…”
Section: Introductionmentioning
confidence: 99%
“…Cancer registration provides a firm basis for cancer control efforts and research into changing patterns of incidence, mortality, survival fundamental information in expressing cancer trends (Park et al, 2013;Brecht et al, 2014), interpret cancer causes (Schlesinger et al, 2013), follow-up patients (Sengoku et al, 2014), evaluate survival (Hanna et al, 2010), enhance planning and promote cancer control policies and individual patients care (Parkin, 2006). Continuous efforts have been made to alleviate the risk of various cancerous diseases in the Asian pacific region (Shin et al, 2012).…”
Section: Introductionmentioning
confidence: 99%